Immuno US 2023

Event Date: Oct. 12, 2023 - Oct. 13, 2023
Location: United States of America, San Diego
Website: Immuno US website
Discuss the latest strategies to harness the immune system for the development of innovative therapeutics.
Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
Agenda at a Glance
Day One
Track 1: Discovery & Development: Cell Therapies & Antibody Approaches
- NextGen cell-based immunotherapies: CAR-T, TCR, and TIL
- Case studies in bispecific antibodies and checkpoint inhibitors
- Workshop: Improving The Therapeutic Index For Cell Engagers
Track 2: Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology
- Biomarker strategies in the era of PD-1 checkpoint combination therapies
- New technologies: CyTOF, mass spec, multiplexing, immunohistochemistry, serum biomarkers
- Spatial biology to improve clinical trial outcomes and biomarker discovery
- Workshop: Harnessing Spatial Technologies For Immunotherapy Research
Day Two
Track 1: Discovery & Development: Intratumoral Immuno- & Combination Therapies & Small Molecules as IO Therapeutics
Part 1 – Intra-tumoral & Combination Therapies
- Oncolytic and non-oncology viruses and agonists
- Cancer vaccine development
- Rationale of different combinations, including combination of IO agents as well as radiotherapy & chemotherapy
Part 2 – Small Molecules as Immuno-Oncology Therapeutics
- Advances in modulating immuno-metabolism and immuno-suppression with small molecules
- New approaches for small molecule IO targets
- Workshop: Small Molecules As IO Targets
Track 2: Translational & Preclinical and Clinical Development
- Preclinical models, including humanised & 3D mouse models
- Translational imaging and screening methods
- Safety & Toxicity considerations
- Approaches to clinical trial design & development